Jubilant Pharmova arm completes studies using novel oral formulation of Remdesivir

Jubilant Pharma has successfully completed "safety and pharmacokinetic/absorption studies in animals and healthy human volunteers in India using a novel oral formulation of Remdesivir against the commercially available injectable formulation of Remdesivir," Jubilant Pharmova said in a filing to BSE.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3tvLtyH
via IFTTT